BRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows

Reuters03-11

March 11 (Reuters) - Novavax Inc NVAX.O:

NOVAVAX INC - ON MARCH 7 RECEIVED NOTICE TERMINATING ADVANCED PURCHASE AGREEMENT DATED JAN 19 2021 WITH HIS MAJESTY KING IN RIGHT OF CANADA
NOVAVAX INC - EXPECTS TO RECOGNIZE $576 MILLION AS PRODUCT REVENUE IN Q1 2025
NOVAVAX- DEAL TERMINATED DUE TO CO NOT GETTING APPROVAL FOR COVID VACCINE USING BULK ANTIGEN MADE AT BIOLOGICS MANUFACTURING CENTRE BY DEC 31 2024

Source text: https://shorturl.at/e4XSS

Further company coverage: NVAX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2518740266?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-11 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2518740266","market":"us","top_or_hot":-1,"title":"BRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows</title></head><body><p><span>March 11 (Reuters)</span><span> - </span>Novavax Inc <span>NVAX.O</span>:</p><ul><li><p><a href=\"https://laohu8.com/S/0A3S.UK\">NOVAVAX INC</a> - ON MARCH 7 RECEIVED NOTICE  TERMINATING ADVANCED PURCHASE AGREEMENT DATED JAN 19 2021 WITH HIS MAJESTY KING IN RIGHT OF CANADA</p></li><li><p>NOVAVAX INC - EXPECTS TO RECOGNIZE $576 MILLION AS PRODUCT REVENUE IN Q1 2025</p></li><li><p>NOVAVAX- DEAL TERMINATED DUE TO CO NOT GETTING APPROVAL FOR COVID VACCINE USING BULK ANTIGEN MADE AT BIOLOGICS MANUFACTURING CENTRE BY DEC 31 2024</p></li></ul><p>Source text: https://shorturl.at/e4XSS</p><p>Further company coverage: <span>NVAX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-11 22:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing shows</title></head><body><p><span>March 11 (Reuters)</span><span> - </span>Novavax Inc <span>NVAX.O</span>:</p><ul><li><p><a href=\"https://laohu8.com/S/0A3S.UK\">NOVAVAX INC</a> - ON MARCH 7 RECEIVED NOTICE  TERMINATING ADVANCED PURCHASE AGREEMENT DATED JAN 19 2021 WITH HIS MAJESTY KING IN RIGHT OF CANADA</p></li><li><p>NOVAVAX INC - EXPECTS TO RECOGNIZE $576 MILLION AS PRODUCT REVENUE IN Q1 2025</p></li><li><p>NOVAVAX- DEAL TERMINATED DUE TO CO NOT GETTING APPROVAL FOR COVID VACCINE USING BULK ANTIGEN MADE AT BIOLOGICS MANUFACTURING CENTRE BY DEC 31 2024</p></li></ul><p>Source text: https://shorturl.at/e4XSS</p><p>Further company coverage: <span>NVAX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4547","symbol_name":"WSB热门概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU07Q:1","article_id":"2518740266","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2518740266","pubTimestamp":1741703672,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing showsMarch 11 (Reuters) - Novavax Inc NVAX.O:NOVAVAX INC - ON MARC","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4547":"WSB热门概念","BK4585":"ETF&股票定投概念","BK4588":"碎股","BK4568":"美国抗疫概念","NVAX":"诺瓦瓦克斯医药","BK4139":"生物科技"},"translate_title":"简报-SEC文件显示，由于错过监管批准截止日期，Novavax面临终止与加拿大的Covid-19疫苗购买协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"BRIEF-Novavax faces termination of Covid-19 vaccine purchase deal with Canada due to missed regulatory approval deadlines, SEC filing showsMarch 11 (Reuters) - Novavax Inc NVAX.O:NOVAVAX INC - ON MARCH 7 RECEIVED NOTICE  TERMINATING ADVANCED PURCHASE AGREEMENT DATED JAN 19 2021 WITH HIS MAJESTY KING IN RIGHT OF CANADANOVAVAX INC - EXPECTS TO RECOGNIZE $576 MILLION AS PRODUCT REVENUE IN Q1 2025NOVAVAX- DEAL TERMINATED DUE TO CO NOT GETTING APPROVAL FOR COVID VACCINE USING BULK ANTIGEN MADE AT BIOLOGICS MANUFACTURING CENTRE BY DEC 31 2024Source text: https://shorturl.at/e4XSSFurther company coverage: NVAX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2518740266"}